Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sampling Plans01:23

Sampling Plans

181
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
181
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Censoring Survival Data01:09

Censoring Survival Data

92
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
92
McNemar's Test01:23

McNemar's Test

247
McNemar's Test is a nonparametric statistical test used to determine if there is a significant difference in proportions between two related groups when the outcome is binary (e.g., yes/no, success/failure). It is beneficial when we have paired data, such as pre-test/post-test designs, where the same subjects are measured under two different conditions. The test is named after the statistician Quinn McNemar, who introduced it in 1947. It is commonly used in situations where subjects are...
247

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A quantitative framework to assess the potential of earlier cancer detection to improve cancer survival.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

OPERA: a new algorithm for patient stratification based on partially ordered risk factors.

Biometrics·2026
Same author

Confidence Interval Construction for Causally Generalized Estimates With Target Sample Summary Information.

Statistics in medicine·2026
Same author

CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast Cancer.

Cancer research·2025
Same author

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes.

Cancer discovery·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
查看所有相关文章

相关实验视频

Updated: Jul 2, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

随机的第二阶段选择设计,有序受约束的层级.

Yi Chen1, Menggang Yu1

  • 1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53726, United States.

Biometrics
|February 16, 2024
PubMed
概括
此摘要是机器生成的。

这项研究为随机二期试验引入了新的统计方法,通过使用患者子组信息来提高效率. 该方法提高了正确选择的概率,并减少了对二进制和时间到事件结果的样本大小.

关键词:
不同类型的患者群体.订单约束的订单限制随机二期临床试验 随机二期临床试验选择设计设计的选择.

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

相关实验视频

Last Updated: Jul 2, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

科学领域:

  • 临床试验方法论 临床试验方法论
  • 生物统计学 生物统计学
  • 药物开发 药物开发

背景情况:

  • 二期试验往往包括异质的患者子组,影响统计效率.
  • 目前的随机二期试验设计往往忽略了在样本大小计算中的患者分层.
  • 单臂II期试验可以通过纳入患者异质性来提高效率.

研究的目的:

  • 为随机二期试验提出新的统计方法,利用分层人群中的自然秩序约束.
  • 在随机二期选择和选设计中提高统计效率.
  • 为了解决在随机二期试验的样本大小计算中缺乏考虑患者分层的问题.

主要方法:

  • 开发了利用自然秩序约束在随机二期设计中的分层人群的方法.
  • 专注于随机的II阶段选择设计,可通用到选设计.
  • 在统计分析中考虑二进制和时间到事件结果.

主要成果:

  • 与不使用订单约束的方法相比,提出的方法提高了统计效率.
  • 在模拟和现实世界的例子中证明了正确选择的更好的概率.
  • 在随机二期试验中显示了所需样本大小的减少.

结论:

  • 在分层人群中使用顺序约束为随机二期试验提供了显著的统计优势.
  • 开发的方法提供了一个更有效的方法来确定样本大小和正确的选择.
  • 这项工作通过改进临床试验设计,有助于更高效和有效的药物开发.